Stanford University
Showing 1-100 of 354 Results
-
Tazbir Ahmed
Postdoctoral Scholar, Ophthalmology
BioDr. Tazbir Ahmed is a clinician-scientist with a focus on neuro-ophthalmology and vision science, bringing expertise in translational research, clinical trials, and medical education. He obtained his medical degree and licensure through the Bangladesh Medical and Dental Council and achieved board certification in Ophthalmology from the Bangladesh College of Physicians and Surgeons.
Motivated by a deep interest in ocular neurodegeneration, inflammation, and metabolic eye disorders, Dr. Ahmed pursued a PhD in Ophthalmology at the University of Tokyo School of Medicine. His doctoral research explored the use of biologics, ocular devices, and experimental models of inflammation to investigate retinal and optic nerve changes in glaucoma, optic neuropathies, and age-related visual decline.
Dr. Ahmed’s multidisciplinary research integrates preclinical disease models, neuroimaging, ocular histochemistry, omics technologies, and electrophysiological methods to elucidate mechanisms of visual pathway dysfunction. He also leverages data science tools to address key issues in ocular public health. -
Ahmad Al-Moujahed, MD, PhD, MPH
Assistant Professor of Ophthalmology (Research/Clinical Trials)
BioDr. Ahmad Al-Moujahed is a board-certified, fellowship-trained ophthalmologist with Stanford Health Care. He is also an assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Al-Moujahed specializes in caring for retinal and macular diseases, as well as inherited retinal degenerations (IRDs), a group of genetic diseases that cause vision loss. He also specializes in vitreoretinal surgery to treat a range of diseases that affect vision. He is one of the only ophthalmologists in the nation with dedicated vitreoretinal surgery and IRD training and expertise. He is committed to providing compassionate care that improves eye health, vision, and quality of life.
As a physician-scientist, Dr. Al-Moujahed’s research focuses on investigating the origins of IRDs and developing novel treatments for these conditions. He is also involved in clinical trials exploring innovative experimental treatments for IRDs.
He is also deeply interested in the intersection of ophthalmology, public health, and global health. He has contributed to the development of educational programs for medical students and vision care initiatives in Syria and Lebanon, with the goal of expanding access to eye care in underserved communities.
Dr. Al-Moujahed has published his research in peer-reviewed journals, including Investigative Ophthalmology & Visual Science, Experimental Eye Research, Stem Cell Research, Scientific Reports, and American Journal of Ophthalmology. He has also published in Ophthalmology Retina; British Journal of Ophthalmology; European Journal of Ophthalmology; Ophthalmic Surgery, Lasers and Imaging Retina; and the International Journal of Retina and Vitreous.
He has also presented at several national conferences, including meetings of the Association for Research in Vision and Ophthalmology, American Society of Retina Specialists, American Academy of Ophthalmology, and Retina Society.
Dr. Al-Moujahed is a member of the American Society of Retina Specialists, American Academy of Ophthalmology, and Association for Research in Vision and Ophthalmology. He is also a member of the Syrian American Medical Society and serves on its Education and Ophthalmology Committee. -
Deborah Alcorn, MD
Associate Professor of Ophthalmology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsGene linkage - tuberous sclerosis; stabismus and, molteno implants; congenital stationary night blindness
-
Haider Ali
Postdoctoral Scholar, Ophthalmology
BioHaider Ali, M.B., B.S. is a Postdoctoral Scholar in the Department of Ophthalmology at Stanford University School of Medicine. With over six years of experience in translational research, his work focuses on advancing innovations in retinal imaging, artificial intelligence, and digital health. He is particularly interested in developing technologies that bridge clinical innovation and real-world impact to improve vision care globally.
-
Tayyeba K. Ali, MD
Adjunct Clinical Associate Professor, Ophthalmology
BioTayyeba K. Ali, MD, a Board Certified ophthalmologist, specializes in complex corneal disease and uveitis. She sees patients at Palo Alto Medical Foundation / Sutter Health in Sunnyvale, CA. Dr. Ali also works as a medical specialist on contract for Google.
Prior to completing two fellowships in cornea, external disease, refractive surgery and uveitis at Bascom Palmer Eye Institute, ranked #1 eye hospital in the United States by U.S. News & World Report, Dr. Ali finished her ophthalmology residency at the Jones Eye Institute / UAMS. She earned her medical degree from Emory University School of Medicine and completed her undergraduate training in English literature and creative writing from Agnes Scott College.
Dr. Ali has received many academic and teaching awards including the Bascom Palmer Fellow of the Year Award and the Jone’s Eye Dean’s Faculty Award. She has delivered dozens of lectures on the national and international level and published numerous meeting abstracts and peer-reviewed journal articles.
As a second generation American, Tayyeba finds herself dwelling on migrant and refugee stories, their need for ethnic and religious identity, and the repercussions of these journeys. She is keenly interested in international medicine, resident education, health technology and taking a closer look at the moral crossroads we face in healthcare. She is the Associated Director for Pegasus Physician Writers at Stanford as well as the Senior Fiction Editor for the medical literary magazine, The Pegasus Review; she has a particular affinity for colons (grammatically, not anatomically, speaking) and semicolons. -
BRIGHT ASARE-BEDIAKO
Postdoctoral Scholar, Ophthalmology
BioDr. Asare-Bediako is a Ghanaian-trained Optometrist who started his career as a Teaching/Research Assistant at the Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. He obtained a doctorate degree in Vision Science from the University of Alabama at Birmingham, US, where he worked on animal models of diabetic retinopathy and hematopoiesis in Prof. Maria Grant’s lab. Currently, he is a postdoctoral scholar in Prof. Mary Elizabeth Hartnett’s lab studying retinopathy of prematurity. His current interests lie in understanding mechanisms of angiogenesis in retinopathy of prematurity and diabetic retinopathy.
-
Gastón A. Ayubi
Postdoctoral Scholar, Ophthalmology
BioGastón A. Ayubi completed his undergraduate studies in physics and electrical engineering, followed by PhD studies in physics at the University of the Republic of Uruguay. As an undergraduate student, in 2008 he started collaborating at the Department of Physics, where he developed a strong interest in phase imaging techniques. In 2022 he joined Stanford University as a postdoc. His role is to develop and test phase contrast imaging methods for both microscopy and retinal imaging.
-
Jill Beyer, OD
Clinical Associate Professor, Ophthalmology
BioJill Beyer, OD, is a Clinical Associate Professor at Stanford University School of Medicine.
Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.
Jill’s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.
After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School. -
Gala Beykin, MD
Clinical Instructor, Ophthalmology
BioDr. Beykin is an ophthalmologist and glaucoma specialist at the Byers Eye Institute at Stanford Health Care. She is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Beykin completed clinical and surgical training in glaucoma at the Byers Eye Institute. She specializes in caring for patients with all types of ophthalmic conditions, including glaucoma and cataract.
She has expertise in clinical trial design and implementation, and studies novel biomarkers and candidate therapeutics for vision protection and restoration in glaucoma. Her research efforts include numerous clinical trials investigating new therapies for eye conditions. Dr. Beykin has participated in multiple studies evaluating drugs targeting retinal disease such as AMD and diabetes-related vision loss, as well as ongoing clinical trials assessing new treatment strategies for neuroprotection, neuroregeneration and neuroenhancement in glaucoma. These include implants that could potentially stop or slow the progression of and help improve vision.
Dr. Beykin has published her work in numerous peer-reviewed journals, including the British Journal of Ophthalmology and Investigative Ophthalmology & Visual Science. She has presented her work at national and international meetings, including those for the International Symposium on Retinal Degeneration and the Association for Research in Vision and Ophthalmology.
She is a member of the Israeli Ophthalmology Society, the Israeli Society for Eye and Vision Research, and the Association for Research in Vision and Ophthalmology. -
Kaiwen Bian
Life Science Research Professional 1, Ophthalmology Research/Clinical Trials
BioVisiting researcher, with interest in the cross section of cognitive science, neuroscience, and computer science / statistics, working on various naturalistic control, planning, and imitation problems.
-
Nathaniel Aidan Blecher
Clinical Assistant Professor, Ophthalmology
BioDr. Nathaniel Blecher is a board-certified, fellowship-trained ophthalmologist who specializes in glaucoma care at Stanford Health Care. He is also a clinical assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
His clinical interests include innovative surgical treatments for glaucoma—including minimally invasive glaucoma surgery (MIGS)—as well as the connection between lifestyle and ocular health. Dr. Blecher provides comprehensive care for the full spectrum of glaucoma, both early-stage and particularly advanced disease.
His individualized approach includes laser therapy, medical management, MIGS procedures, and more complex interventions such as tube shunt placement and trabeculectomy. He also treats coexisting conditions like cataracts, ensuring patients receive coordinated, whole-eye care.
Dr. Blecher’s research interests include treatments for pseudophakic angle closure, which is a rare situation when high pressure inside the eye suddenly develops despite cataract surgery. He has also studied the finer details of correctly detecting glaucoma progression based on optical coherence tomography (OCT) analysis, considering the changes that can be seen from comorbid conditions such as hypertension and diabetes.
Dr. Blecher’s research has been published in leading peer-reviewed journals, including Ophthalmology, Ophthalmic Plastic & Reconstructive Surgery, and Ophthalmology Case Reports. He has presented internationally on topics such as MIGS and complex glaucoma management.
He is a member of the American Academy of Ophthalmology and the American Glaucoma Society. -
Mark S. Blumenkranz, MD, MMS
H. J. Smead Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsClinical Interest and Research
My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Administrative and Community Service
I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations. -
Kevin Chuen Wing Chan
Associate Professor of Ophthalmology (Research/Clinical Trials) and, by courtesy, of Bioengineering
Current Research and Scholarly Interests(1) MR ocular imaging and neuroimaging of degeneration, development, protection, plasticity, and regeneration in humans and experimental animal models.
(2) Structural, metabolic, physiological, and functional relationships between eye, brain, and behavior in health and disease. -
Robert Chang, MD
Professor of Ophthalmology
Current Research and Scholarly InterestsI'm interested in developing a best in class glaucoma registry, utilizing modern algorithm techniques on imaging, text, and biologic data for precision health predictive analytics in glaucoma diagnosis and treatment, validating new medical devices and technologies, especially portable ones, and working on implementation science
-
Siyu Chen
Postdoctoral Scholar, Ophthalmology
BioMy research focuses on the development and optimization of CRISPR gene editing tools. iPSC modeling and developing gene therapies for Lowe Syndrome and Glaucoma.
-
Zheng Chen, OD
Clinical Assistant Professor, Ophthalmology
BioDr. Chen is an optometrist with the Byers Eye Institute and a clinical assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Chen diagnoses and treats a range of eye conditions, including refractive errors, glaucoma, cataracts, and diabetic retinopathy. Her clinical experience is in routine and emergency eye care, pre- and post-surgical eye care, and medical management of eye diseases. She delivers patient-focused care, quickly establishing rapport and working effectively with pediatric, geriatric, and culturally diverse populations.
Dr. Chen is a member of Beta Sigma Kappa, an international optometric honor society. -
E.J. Chichilnisky
John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering
On Leave from 2026-08-01 To 2026-12-01Current Research and Scholarly InterestsFunctional circuitry of the retina and design of retinal prostheses
-
Ximena Corso Díaz
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsWe are interested in unraveling the roles of RNA-binding proteins (RBPs) and regulatory RNAs in retinal development and homeostasis.
RNA-binding proteins mediate functional integration of transcriptional and post-transcriptional machineries influencing various aspects of gene expression and RNA metabolism. Several RBPs have cell-type enriched expression patterns in the retina or cause blinding diseases, however their role in retinal development and function is poorly understood. We have identified several RBPs that interact with the photoreceptor-specific transcription factor NRL and are likely involved in development and homeostasis of this retinal cell-type. We are pursuing the following lines of research:
1) RBPs in retinal development and degeneration. We will study the role of RBPs in regulating retinal development and maintaining homeostasis. We will focus on RBPs enriched in the retina, their interactions with retinal transcription factors like NRL, and their relevance to retinal diseases.
2) RBPs in R-loop regulation in the retina. R-loops are triple-stranded structures created when RNA anneals to one of the strands of the DNA duplex. R-loops have many regulatory roles during gene expression and their dysregulation can be detrimental to genome integrity. We observed that R-loops are dynamic during retinal development and identified key R-loop-associated RBPs that are enriched in rod photoreceptors and that interact with the transcription factor NRL. We will study the role of R-loops and their regulatory RBPs in retinal development and homeostasis.
3) Chromatin-associated regulatory RNAs through the retina lifespan. Chromatin-associated RNAs contribute to the dynamic regulation of gene expression, chromatin structure, and genome organization, playing essential roles in various biological processes, including development, differentiation, and disease. We will study how regulatory RNAs, together with their cognate RBPs, influence expression programs and chromatin dynamics through the retina lifespan. -
Muhammad Najam Dar
Affiliate, Ophthalmology Research/Clinical Trials
BioDr. Muhammad Najam Dar is affiliate researcher at Stanford University and specializing in electrophysiological signal-based ophthalmological solutions. He holds a Ph.D. in Computer Engineering from the National University of Sciences and Technology (NUST), Pakistan, and was awarded the prestigious Erasmus Mundus Fellowship for his doctoral research at City, University of London, United Kingdom.
With a strong interdisciplinary foundation in biomedical signal and image analysis, computer vision, and deep learning, Dr. Dar has made significant contributions to both academia and industry. His research focuses on developing cutting-edge AI-driven diagnostic tools, wearable smart device signal processing, and systemic workflow optimizations for healthcare applications. His work integrates machine learning, medical imaging, and human-centered design to advance next-generation ophthalmological and biomedical solutions.
Beyond research, Dr. Dar has extensive experience in teaching, mentorship, and academic leadership, fostering innovation in AI-driven healthcare among the next generation of engineers and scientists. His ability to bridge theoretical knowledge with real-world applications makes him an invaluable asset in advancing biomedical engineering, artificial intelligence in healthcare, and translational research. Dr. Dar aims to become a leader in AI-driven healthcare solutions by advancing cutting-edge research, fostering industry collaborations, integrating design thinking into innovative medical technologies, mentoring and inspiring students and peers, empowering them to to drive transformative advancements in healthcare and improve lives globally. -
Charles DeBoer, MD, PhD
Assistant Professor of Ophthalmology
BioDr. DeBoer is a board-certified, fellowship-trained vitreoretinal surgeon with Stanford Health Care’s Byers Eye Institute and a clinical instructor in the Department of Ophthalmology.
He specializes in retinal and macular diseases, treating a range of conditions such as retinal tears, diabetic retinopathy, retinal vein occlusions, macular pucker, macular hole, macular degeneration, retinal detachment, and other complex retinal conditions. Dr. DeBoer incorporates state-of-the-art treatments in personalized, comprehensive care plans for each of his patients. He is dedicated to training future vitreoretinal surgeons and passionate about helping patients through both direct care and research.
Dr. DeBoer’s scientific background in micro- and nanofabrication, mechanical and electrical engineering, and medicine drives his research interests in implantable devices and surgical instruments. While completing his PhD, Dr. DeBoer co-invented a biomimetic accommodating intraocular lens (IOL) that treats both cataracts and presbyopia.
He continues researching microdevices, focusing on extended drug delivery from the lens capsule and microelectromechanical systems (MEMS)-enabled implantable devices. Dr. DeBoer’s research experience spans topics such as material science, drug delivery, IOL design, microfabrication, 3D printing, and medical device design. He has received grant funding for his work and has 12 patents in the field of ophthalmology.
Dr. DeBoer’s work has been published in peer-reviewed journals, including the American Journal of Ophthalmology. He has authored book chapters and presented to his peers at national and international meetings, including meetings of the American Society of Retina Specialists and the Association for Research in Vision and Ophthalmology.
Dr. DeBoer is a member of the American Academy of Ophthalmology and American Society of Retina Specialists. He is also part of the Society of HEED Fellows and Ronald G. Michels Fellowship Foundation. -
Boxiong Deng
Postdoctoral Scholar, Ophthalmology
BioBoxiong Currently is a postdoctoral fellow in Dr. Sui Wang's lab within Stanford University's Department of Ophathalmology, focusing on the interplay between retinal Müller glial cells and the vasculature in diabetic conditions.
-
Shazia Dharssi, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Shazia Dharssi is a board-certified ophthalmologist and fellowship-trained oculoplastic and reconstructive surgeon with Stanford Health Care. She is also a clinical assistant professor in the Department of Ophthalmology, Division of Ophthalmic Plastic and Reconstructive Surgery at Stanford University School of Medicine.
Dr. Dharssi specializes in diagnosing and treating conditions that affect the eyelid and surrounding structures of the orbit. She specializes in advanced oculoplastic and reconstructive surgery, including both functional and cosmetic eyelid surgery, tear duct surgery, and orbital surgeries. Her expertise also includes diagnosing and treating facial nerve palsy, ptosis, thyroid eye disease, ocular cancers, and skin cancer that affects the eyes. Dr. Dharssi is dedicated to providing personalized, high-quality care to achieve the best possible outcomes for her patients.
Dr. Dharssi’s research focuses on applying deep learning and related computational tools to improve the diagnosis and treatment of ocular diseases, including age-related macular degeneration. She is particularly interested in developing technologies that enhance precision, efficiency, and patient outcomes in ophthalmic care. Her long-term goal is to integrate these innovations into the field of oculoplastic surgery to advance both functional and reconstructive outcomes.
Dr. Dharssi has published her research in peer-reviewed journals, such as Ophthalmic Epidemiology, Ophthalmic Plastic & Reconstructive Surgery, Journal of Academic Ophthalmology, and Ophthalmology. She has presented to her peers at international and national meetings, including the American Academy of Ophthalmology (AAO), the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), the Association for Research in Vision and Ophthalmology (ARVO), and Women in Ophthalmology (WIO).
Dr. Dharssi is a candidate member of ASOPRS and a member of AAO, ARVO, and WIO. -
Diana Do, MD
Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Do's research focuses on collaborative clinical trials to investigate novel treatments for retinal vascular diseases and ocular inflammation. She performs research to develop state of the art therapies for age-related macular degeneration, diabetic eye disease, retinal vein occlusion, retinal inflammation, and retinal detachment.
-
Alfredo Dubra, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsOur lab seeks to help the early diagnosing and monitoring progression of ocular, vascular, neurodegenerative and systemic diseases through novel non-invasive optical ophthalmic imaging. We pursue this goal through a multidisciplinary approach that integrates optics, computer science, vision science, electrical engineering and other engineering disciplines.
-
Peter R. Egbert, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsOcular pathology of shaken baby syndrome
-
Mohammad Eslami
Visiting Scholar, Ophthalmology Research/Clinical Trials
BioI am a faculty member in the Department of Ophthalmology at Harvard Medical School and an AI scientist at Mass Eye and Ear, specializing in artificial intelligence for healthcare. I am currently visiting Stanford Medicine to develop new collaborations in ophthalmology and surgical AI.
My research focuses on surgical AI, clinical decision support and intervention planning, and AI-based early diagnosis and prognosis. I am particularly interested in developing trustworthy and clinically useful AI systems and translating research findings into tools that can improve patient care and outcomes.
Personal webpage: https://mohaes.github.io/ -
Houri Esmaeilkhanian
Affiliate, Ophthalmology Research/Clinical Trials
BioDr. Esmaeilkhanian is an accomplished medical doctor who graduated from Iran University of Medical Sciences (IUMS) in 2018. Her passion for ophthalmology ignited during her medical studies, leading her to a focused research career in this field. After earning her degree, she dedicated her efforts to serving underprivileged communities while continuing her research at the Eye and Ear Research Institute of IUMS. In 2021, she advanced to the Doheny Eye Institute at UCLA, working in Prof. Vas Sadda’s lab, where she made significant contributions to research on diabetic retinopathy and age-related macular degeneration (AMD), further honing her clinical expertise. In March 2023, Dr. Esmaeilkhanian joined Byers Eye Institute, pioneering treatments for corneal injuries using innovative stem cell therapies and hydrogels. Additionally, she plays a crucial role in collaborative clinical studies involving the first FDA-approved AI device for diagnosing diabetic retinopathy impacting patient care in both the Bay Area and underserved regions.
-
Muneeb A. Faiq
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioDr. Muneeb A. Faiq is a behavioral and metabolic neuroscientist and ophthalmology researcher whose work spans molecular biology, neuroimaging, and systems neuroscience. He has made several foundational contributions, including the first functional cloning of CYP1B1 in congenital glaucoma, implicating retinoic-acid signaling in Zika virus–associated microcephaly, identifying central insulin resistance as a mechanistic basis for glaucoma, and providing the first in vivo evidence for a glymphatic pathway in the optic nerve. With more than 100 peer-reviewed publications and over 4,000 citations, Dr. Faiq has earned international recognition, including the Emerging Vision Scientist Award – 2019 from the Alliance for Eye and Vision Research. He is widely regarded as the pioneer and principal architect of the discipline of psychosomatic ophthalmology, a field he helped conceptualize and establish, leading to the integration of ophthalmic clinical practice with mindfulness-based and psychosomatic medicine frameworks. Dr. Faiq is currently advancing the concept of neurometabolic syntax in vision and brain function — a unifying systems-level framework that integrates genetics, metabolism, and behavior to reconceptualize ophthalmic and neurological diseases through a mechanistic and interdisciplinary lens. He has been selected for the prestigious Asia Pacific Academy of Ophthalmology (APAO) Achievement Award 2026.
-
Ann Caroline Fisher, MD
Clinical Professor, Ophthalmology
BioCaroline Fisher, MD, is a Clinical Professor of Ophthalmology at Stanford University Hospital and Clinics. She specializes in cataract and glaucoma surgery, including minimally invasive glaucoma surgery.
She completed her undergraduate education at Stanford University, obtaining both a Bachelor of Science degree in Biology and a Bachelor of Arts degree in Spanish, with Departmental Honors. She earned her medical degree from Stanford University School of Medicine and then went on to her internship at the University of Pennsylvania Presbyterian Hospital. She completed her ophthalmology residency at NYU/ Manhattan Eye, Ear, Throat Hospital. She then returned to Stanford for her Glaucoma Fellowship.
Dr. Fisher is Director of the Stanford Belize Vision Clinic, dedicated to promoting eye health and care in Belize, and providing an international rotation for Stanford Ophthalmology Residents. She is also an Office of Faculty Development and Engagement Liaison and is currently one of the Stanford Network for Advancement and Promotion (SNAP) Cohort Leaders. Dr. Fisher is the Director of Development and Engagement for the Department of Ophthalmology. -
Michael W. Gaynon, MD
Clinical Professor, Ophthalmology
Current Research and Scholarly Interests-Retinal Vascular Disease
-Angiogenesis
-Retinopathy of Prematurity
-Sustained Release Drug Delivery Systems
